- FDA approves Orca Bio’s cell therapy to improve transplant outcomesThe FDA gave the go-ahead to Orca Bio’s T cell therapy that would reduce transplant-related complications for blood cancer patients. The therapy will be branded as Tregzi, an homage to the regula…Endpoints · 25d ago↗ source
- STAT+: The moment Anthropic convinced me it’s serious about scienceAI Prognosis: The release of Claude Science suggests big model makers are getting serious about real science, and not just flashy problems.STAT · 25d ago↗ source
- BridgeBio adds $1B as it prepares three more drug launchesBridgeBio Pharma has reloaded with about $1 billion in a preferred equity deal to bolster its reserves ahead of three potential drug launches over the next year. The California biotech, which for…